A preliminary analysis showed that CureVac’s mRNA vaccine had an efficacy of just 47 percent. “This is pretty devastating for them,” one expert said.
Published: June 16, 2021 at 11:25PM
from NYT Health https://ift.tt/2TBzX7Y
A preliminary analysis showed that CureVac’s mRNA vaccine had an efficacy of just 47 percent. “This is pretty devastating for them,” one expert said.
Published: June 16, 2021 at 11:25PM
from NYT Health https://ift.tt/2TBzX7Y